Angelica Peebles,Annika Kim Constantino,Jacob Pramuk, Author at V3 Media

Sarepta shares plunge 40% as future of its gene therapy appears at risk

Douglas Ingram, president and chief executive officer of Sarepta Therapeutics Inc., during the Forbes Healthcare Summit…